Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Laguna

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Actas Dermo-Sifiliograficas|December 23, 2014
Vertically orientated telangiectasias and pruritus on the thorax of a patient with early superior vena cava syndrome secondary to a malignant thymomaC Laguna
Anales De La Real Academia Nacional De Medicina|January 1, 1980
[Juvenile rheumatoid arthritis: consideration on its clinical course and diagnosis]C Laguna Serrano
Anales De La Real Academia Nacional De Medicina|January 1, 1982
[Congenital errors of metabolism: phenylketonuria and hyperphenylalanemias]C Laguna Serrano
World Journal of Gastroenterology|September 13, 2012
Opposite fates of fructose in the development of metabolic syndromeMarta Alegret, Juan C Laguna
Pharmacogenomics|March 3, 2012
Regulation of gene expression in atherosclerosis: insights from microarray studies in monocytes/macrophagesJuan C Laguna, Marta Alegret
Cardiovascular Drugs and Therapy|September 19, 2012
Dabigatran etexilate: another double-edged drug? : editorial to: "the beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice" by N. Kadoglou et alJuan C Laguna, Marta Alegret
Actas Dermo-Sifiliograficas|May 27, 2008
[Superficial migratory thrombophlebitis: a clinical and histologic review of 8 cases]C Laguna, V Alegre, A Pérez
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Peroxisome proliferator-activated receptors and the control of inflammationA Cabrero, J C Laguna, M Vázquez
Actas Dermo-Sifiliograficas|April 3, 2007
[Neutrophilic dermatosis of the dorsal hands]C Laguna, J J Vilata, B Martín
Cardiovascular Drug Reviews|February 22, 2003
Pharmacology of the ACAT inhibitor avasimibe (CI-1011)Gemma Llaverías, Juan C Laguna, Marta Alegret
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Actas Dermo-Sifiliograficas|December 23, 2014
Vertically orientated telangiectasias and pruritus on the thorax of a patient with early superior vena cava syndrome secondary to a malignant thymomaC Laguna
Anales De La Real Academia Nacional De Medicina|January 1, 1980
[Juvenile rheumatoid arthritis: consideration on its clinical course and diagnosis]C Laguna Serrano
Anales De La Real Academia Nacional De Medicina|January 1, 1982
[Congenital errors of metabolism: phenylketonuria and hyperphenylalanemias]C Laguna Serrano
World Journal of Gastroenterology|September 13, 2012
Opposite fates of fructose in the development of metabolic syndromeMarta Alegret, Juan C Laguna
Pharmacogenomics|March 3, 2012
Regulation of gene expression in atherosclerosis: insights from microarray studies in monocytes/macrophagesJuan C Laguna, Marta Alegret
Cardiovascular Drugs and Therapy|September 19, 2012
Dabigatran etexilate: another double-edged drug? : editorial to: "the beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice" by N. Kadoglou et alJuan C Laguna, Marta Alegret
Actas Dermo-Sifiliograficas|May 27, 2008
[Superficial migratory thrombophlebitis: a clinical and histologic review of 8 cases]C Laguna, V Alegre, A Pérez
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Peroxisome proliferator-activated receptors and the control of inflammationA Cabrero, J C Laguna, M Vázquez
Actas Dermo-Sifiliograficas|April 3, 2007
[Neutrophilic dermatosis of the dorsal hands]C Laguna, J J Vilata, B Martín
Cardiovascular Drug Reviews|February 22, 2003
Pharmacology of the ACAT inhibitor avasimibe (CI-1011)Gemma Llaverías, Juan C Laguna, Marta Alegret
Pageof 14